Clinical trial
Aggressive Smoking Cessation Therapy Among People at Elevated Cardiovascular Risk (ASAP) Trial
NCT05257629 is registered in ClinicalTrials.gov with Sir Mortimer B. Davis - Jewish General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Aggressive Smoking Cessation Therapy Among People at Elevated Cardiovascular Risk (ASAP) Trial
- Lead sponsor
- Sir Mortimer B. Davis - Jewish General Hospital
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- February 2, 2023
- Completion date
- March 7, 2027
- Enrollment
- 798 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.